SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported): October 25, 2005

 

Commission file number 001-12215

 

Quest Diagnostics Incorporated

1290 Wall Street West

Lyndhurst, NJ 07071

(201) 393-5000

 

Delaware

(State of Incorporation)

 

16-1387862

(I.R.S. Employer Identification Number)

 

 

 

 

 

 


 

 

Item 8.01. Other Information

The Company announced the proposed offering and the pricing of its Senior Notes due 2010 and its Senior Notes due 2015 in press releases dated October 25, 2005, which are attached as exhibits 99.1 and 99.2 hereto and incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits

 

c.

Exhibits

 

 

99.1 Press release of Quest Diagnostics Incorporated dated October 25, 2005, announcing the proposed offering of its Senior Notes.

   
 

99.2 Press release of Quest Diagnostics Incorporated dated October 25, 2005, announcing  the pricing of its Senior Notes.

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  October 28, 2005
     
  QUEST DIAGNOSTICS INCORPORATED
     

 

By:

/s/ Sirisha Gummaregula

 

Sirisha Gummaregula

 

 

Assistant General Counsel and

 

 

Corporate Secretary